Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -88.28% is 76% below its 4-year average of -50.08%, near the low end of its 4-year range (-88.28%–-18.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.04% below its 12-month average of -76.07%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -88.28%.
RETURN ON INVESTED CAPITAL (ROIC)
-88.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-76.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-57.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.04%
CURRENT VS 3Y AVG
-52.38%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.43%
median of 514 covered companies
CURRENT VS SECTOR MEDIAN
-200.01%
vs the sector median at left
Acrivon Therapeutics, Inc. Common Stock
Market Cap
$87.10M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-76.07%
3Y Avg
-57.93%
5Y Avg
N/A
Market Cap
$87.54M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$88.63M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$85.52M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-42.77%
3Y Avg
-39.33%
5Y Avg
-39.33%
Market Cap
$87.50M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$89.11M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
Market Cap
$84.52M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$85.83M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
Market Cap
$89.78M
Return on Invested Capital (ROIC)
-34.10%
TTM Avg
-61.58%
3Y Avg
-76.39%
5Y Avg
-65.18%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock (ACRV) | $87.10M | -88.28% | -76.07% | -57.93% | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.54M | 12.79% | 17.38% | -11.40% | -8.36% |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | -159.30% | -82.85% | -66.58% | -50.22% |
| Citius Oncology, Inc. (CTOR)vs › | $85.52M | -88.72% | -42.77% | -39.33% | -39.33% |
| Conexeu Sciences Inc. (CNXU)vs › | $87.50M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 8.16% | 0.11% | -4.79% | -3.69% |
| Humacyte, Inc. (HUMA)vs › | $84.52M | -90.27% | -103.33% | -85.38% | -72.83% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.83M | -109.43% | -208.02% | -178.83% | -203.50% |
| Equillium, Inc. (EQ)vs › | $89.78M | -34.10% | -61.58% | -76.39% | -65.18% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $81.54M | -100.35% | -639.99% | -358.78% | -266.51% |
ROIC
-88.3%
ROE
-85.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -88.28% |
| 2026-03-31 | -85.10% |
| 2025-12-31 | -73.75% |
| 2025-09-30 | -68.21% |
| 2025-06-30 | -65.04% |
| 2025-03-31 | -57.24% |
| 2024-12-31 | -49.44% |
| 2024-09-30 | -42.68% |
| 2024-06-30 | -34.79% |
| 2024-03-31 | -63.13% |
| 2023-12-31 | -53.70% |
| 2023-09-30 | -39.49% |
| 2023-06-30 | -32.30% |
| 2023-03-31 | -24.22% |
| 2022-12-31 | -18.69% |
| 2022-09-30 | -33.18% |
| 2022-06-30 | -22.17% |
